REGEN BIOPHARMA INC RGBP

$0.00 +0.00% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-17 View →
8-K 8-K 2026-07-15 View →
10-Q 10-Q 2026-05-14 View →
8-K 8-K 2026-03-04 View →
10-Q 10-Q 2026-02-13 View →
8-K 8-K 2026-02-02 View →
8-K 8-K 2026-01-21 View →
10-K 10-K 2025-12-30 View →
8-K 8-K 2025-11-13 View →
8-K 8-K 2025-10-03 View →
8-K 8-K 2025-09-19 View →
10-Q 10-Q 2025-08-11 View →
8-K 8-K 2025-08-07 View →
8-K 8-K 2025-08-01 View →
8-K 8-K 2025-06-11 View →
10-Q 10-Q 2025-05-28 View →
10-Q 10-Q 2025-05-16 View →
10-K 10-K 2025-05-13 View →
8-K 8-K 2025-05-13 View →
8-K Current report (material event) 2025-04-07 View →
8-K Current report (material event) 2024-11-29 View →
8-K Current report (material event) 2024-09-18 View →
8-K Current report (material event) 2024-09-13 View →
10-Q 10-Q 2024-08-13 View →
8-K 8-K 2024-05-29 View →
8-K 8-K 2024-05-23 View →
8-K 8-K 2024-05-10 View →
8-K 8-K 2024-04-29 View →
10-Q 10-Q 2024-04-24 View →
8-K 8-K 2024-02-09 View →
10-Q 10-Q 2024-01-19 View →
10-K 10-K 2023-11-20 View →
S-1 S-1 2023-09-25 View →
8-K 8-K 2023-09-18 View →
10-Q 10-Q 2023-07-25 View →
10-Q 10-Q 2023-04-18 View →
S-1 S-1 2023-04-13 View →
8-K 8-K 2023-03-21 View →
8-K 8-K 2023-02-07 View →
10-Q 10-Q 2023-01-19 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.00
Market Cap
52-Week Range
$0.00 $0.03
Average Volume
17.07 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.